Clinical Trials for Ever Neuro Pharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Ever Neuro Pharma

Clinical Trials (4)

NCT06489925
Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion
EARLY_PHASE1Not yet recruiting
20 participants
Started: Jul 31, 2024 · Completed: May 31, 2026
2 conditions2 sponsors0 locations
NCT05755997
CERebrolysin In CADASIL
PHASE2Active, not recruiting
30 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT04427241
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
PHASE4Not yet recruiting
12 participants
Started: Jun 1, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06273020
Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke
PHASE4Recruiting
60 participants
Started: Nov 17, 2022 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location